Our findings are consistent with prior studies showing higher SNAP-25, synaptotagmin-1, GAP-43, and neurogranin levels in CSF are associated with cognitive impairment in AD (33–35), which may be linked to synapse degeneration in the brain (72). Here, GAP43 is linked to Alzheimer disease.